The Effect of AGE on the Immune System
EAGESIS II
The Effect of Aged Garlic Extract Supplementation on the Immune System
1 other identifier
interventional
91
1 country
2
Brief Summary
This is a nutritional intervention study using healthy overweight/obese humans to investigate if a supplement made from aged garlic extract has an impact on immunity. Following a baseline blood draw, participants will consume the capsules (garlic or placebo) for 42 days, at which time a second blood draw will occur. Tests for immune function and inflammation will be performed on both the baseline and 42 day samples. The investigators anticipate that the immune functions and biomarkers that are inflammatory in an overweight/obese population will be returning to normal after 42 days of consumption of this supplement. The investigators predict that AGE supplementation will benefit immunity and improve function while reducing inflammation in a stressed population (inflamed obese).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable healthy
Started Jan 2014
Typical duration for not_applicable healthy
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 8, 2013
CompletedFirst Posted
Study publicly available on registry
October 10, 2013
CompletedStudy Start
First participant enrolled
January 1, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2015
CompletedFebruary 26, 2016
February 1, 2016
1.8 years
October 8, 2013
February 25, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Markers of immune health
Number and function of gamma delta T-cells and monocytes
6 weeks
Secondary Outcomes (1)
Markers of inflammation
6 weeks
Other Outcomes (1)
Serum antioxidant status (compliance)
6 weeks
Study Arms (2)
Placebo
PLACEBO COMPARATORPlacebo Group
Aged Garlic Extract Supplementation
EXPERIMENTALAged Garlic Extract Supplementation Group
Interventions
Subjects will be asked to consume three (3) capsules of 600 mg aged garlic extract (AGE) with food twice a day, for a total of 3.6 grams per day.
To assess for eligible study participants, the research team will use the Cholestech LDX® System (Alere™ Inc, Waltham, MA) to analyze finger-prick blood samples. This is an efficient and economical point of care testing for c-Reactive Protein (CRP), cholesterol and related lipids, and blood glucose, as diagnostic tools which provide information for immediate risk assessment and therapeutic monitoring of heart disease, inflammatory disorders and diabetes. Each finger prick will be treated individually.
Participants will be asked to consume three (3) placebo capsules with food twice a day.
Eligibility Criteria
You may qualify if:
- ages 25-65
- BMI \> or = to 30 kg/m2
- willing to discontinue dietary supplements
- cRP between 2 and 10 mg/L
You may not qualify if:
- medication for hypertension, high cholesterol, heart failure, angina, etc
- diagnoses of diabetes, metabolic syndrome, arthritis, severe allergies, or any other compromised immune condition
- blood pressure \> 135/85 mmHg
- serum triglycerides \> 150 mg/dl
- HDL cholesterol \< 40 mg/dl for men or \< 50 mg/dl for women
- fasting glucose \> 110 mg/dl
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Food Science & Human Nutrition Building, University of Florida
Gainesville, Florida, 32611, United States
University of Florida
Gainesville, Florida, 32611, United States
Related Publications (1)
Xu C, Mathews AE, Rodrigues C, Eudy BJ, Rowe CA, O'Donoughue A, Percival SS. Aged garlic extract supplementation modifies inflammation and immunity of adults with obesity: A randomized, double-blind, placebo-controlled clinical trial. Clin Nutr ESPEN. 2018 Apr;24:148-155. doi: 10.1016/j.clnesp.2017.11.010. Epub 2018 Jan 3.
PMID: 29576354DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Susan Percival, PhD
University of Florida
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 8, 2013
First Posted
October 10, 2013
Study Start
January 1, 2014
Primary Completion
November 1, 2015
Study Completion
November 1, 2015
Last Updated
February 26, 2016
Record last verified: 2016-02